C
CORMEDIX INC
NASDAQ: CRMD (CorMedix Inc.)
Kemas kini terakhir: 1 jam lalu7.26
0.07 (0.97%)
| Penutupan Terdahulu | 7.19 |
| Jumlah Dagangan | 1,255,990 |
| Harga / Pendapatan (P/E Ke hadapan) | 46.51 |
| Harga / Jualan (P/S) | 1.54 |
| Harga / Buku (P/B) | 1.30 |
| Julat 52 Minggu |
| Margin Keuntungan | 20.81% |
| Margin Operasi (TTM) | 51.49% |
| EPS Cair (TTM) | 0.250 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.41% |
| Nisbah Semasa (MRQ) | 4.21 |
| Aliran Tunai Operasi (OCF TTM) | -13.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.07 M |
| Pulangan Atas Aset (ROA TTM) | 8.31% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | CorMedix Inc. | Bercampur | Menurun |
AISkor Stockmoo
-0.1
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -0.14 |
|
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.08% |
| % Dimiliki oleh Institusi | 34.20% |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |